98 related articles for article (PubMed ID: 12635144)
21. Fibroblast growth factor 2 induces differentiation and apoptosis of Askin tumour cells.
Kim MS; Kim CJ; Jung HS; Seo MR; Juhnn YS; Shin HY; Ahn HS; Thiele CJ; Chi JG
J Pathol; 2004 Jan; 202(1):103-12. PubMed ID: 14694527
[TBL] [Abstract][Full Text] [Related]
22. Hepatocyte growth factor/c-Met signaling promotes the progression of experimental human neuroblastomas.
Hecht M; Papoutsi M; Tran HD; Wilting J; Schweigerer L
Cancer Res; 2004 Sep; 64(17):6109-18. PubMed ID: 15342394
[TBL] [Abstract][Full Text] [Related]
23. Activin A suppresses neuroblastoma xenograft tumor growth via antimitotic and antiangiogenic mechanisms.
Panopoulou E; Murphy C; Rasmussen H; Bagli E; Rofstad EK; Fotsis T
Cancer Res; 2005 Mar; 65(5):1877-86. PubMed ID: 15753386
[TBL] [Abstract][Full Text] [Related]
24. Rho exchange factor ECT2 is induced by growth factors and regulates cytokinesis through the N-terminal cell cycle regulator-related domains.
Saito S; Tatsumoto T; Lorenzi MV; Chedid M; Kapoor V; Sakata H; Rubin J; Miki T
J Cell Biochem; 2003 Nov; 90(4):819-36. PubMed ID: 14587037
[TBL] [Abstract][Full Text] [Related]
25. Mutation of Vav1 adaptor region reveals a new oncogenic activation.
Razanadrakoto L; Cormier F; Laurienté V; Dondi E; Gardano L; Katzav S; Guittat L; Varin-Blank N
Oncotarget; 2015 Feb; 6(4):2524-37. PubMed ID: 25426554
[TBL] [Abstract][Full Text] [Related]
26. Vav1: A Dr. Jekyll and Mr. Hyde protein--good for the hematopoietic system, bad for cancer.
Katzav S
Oncotarget; 2015 Oct; 6(30):28731-42. PubMed ID: 26353933
[TBL] [Abstract][Full Text] [Related]
27. Identification of the Drosophila melanogaster homologue of the mammalian signal transducer protein, Vav.
Dekel I; Russek N; Jones T; Mortin MA; Katzav S
FEBS Lett; 2000 Apr; 472(1):99-104. PubMed ID: 10781813
[TBL] [Abstract][Full Text] [Related]
28. Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis.
Fernandez-Zapico ME; Gonzalez-Paz NC; Weiss E; Savoy DN; Molina JR; Fonseca R; Smyrk TC; Chari ST; Urrutia R; Billadeau DD
Cancer Cell; 2005 Jan; 7(1):39-49. PubMed ID: 15652748
[TBL] [Abstract][Full Text] [Related]
29. Detection and identification of Vav1 protein in primary cultured murine cerebellar neurons and in neuroblastoma cells (SH-SY5Y and Neuro-2a).
Betz R; Sandhoff K; Fischer KD; van Echten-Deckert G
Neurosci Lett; 2003 Mar; 339(1):37-40. PubMed ID: 12618295
[TBL] [Abstract][Full Text] [Related]
30. Gene expression and protein localisation of calcyclin, a calcium-binding protein of the S-100 family in fresh neuroblastomas.
Tonini GP; Fabretti G; Kuznicki J; Massimo L; Scaruffi P; Brisigotti M; Mazzocco K
Eur J Cancer; 1995; 31A(4):499-504. PubMed ID: 7576953
[TBL] [Abstract][Full Text] [Related]
31. Vav1 promotes lung cancer growth by instigating tumor-microenvironment cross-talk via growth factor secretion.
Sebban S; Farago M; Rabinovich S; Lazer G; Idelchuck Y; Ilan L; Pikarsky E; Katzav S
Oncotarget; 2014 Oct; 5(19):9214-26. PubMed ID: 25313137
[TBL] [Abstract][Full Text] [Related]
32. Unraveling the Oncogenic Potential of VAV1 in Human Cancer: Lessons from Mouse Models.
Shalom B; Salaymeh Y; Risling M; Katzav S
Cells; 2023 Apr; 12(9):. PubMed ID: 37174676
[TBL] [Abstract][Full Text] [Related]
33. Vav1 in hematologic neoplasms, a mini review.
Oberley MJ; Wang DS; Yang DT
Am J Blood Res; 2012; 2(1):1-8. PubMed ID: 22432082
[TBL] [Abstract][Full Text] [Related]
34. Vav1 mutations: What makes them oncogenic?
Farago M; Yarnitzky T; Shalom B; Katzav S
Cell Signal; 2020 Jan; 65():109438. PubMed ID: 31654719
[TBL] [Abstract][Full Text] [Related]
35. Vav1 accelerates Ras-driven lung cancer and modulates its tumor microenvironment.
Shalom B; Farago M; Salaymeh Y; Sebban S; Risling M; Pikarsky E; Katzav S
Cell Signal; 2022 Sep; 97():110395. PubMed ID: 35752351
[TBL] [Abstract][Full Text] [Related]
36. Vav1 Promotes B-Cell Lymphoma Development.
Shalom B; Farago M; Salaymeh Y; Sebban S; Pikarsky E; Katzav S
Cells; 2022 Mar; 11(6):. PubMed ID: 35326399
[TBL] [Abstract][Full Text] [Related]
37. Nuclear proteome analysis reveals a role of Vav1 in modulating RNA processing during maturation of tumoral promyelocytes.
Bertagnolo V; Grassilli S; Petretto A; Lambertini E; Astati L; Bruschi M; Brugnoli F; Nika E; Candiano G; Piva R; Capitani S
J Proteomics; 2011 Dec; 75(2):398-409. PubMed ID: 21856460
[TBL] [Abstract][Full Text] [Related]
38. Telomerase expression in primary neuroblastomas.
Reynolds CP; Zuo JJ; Kim NW; Wang H; Lukens JN; Matthay KK; Seeger RC
Eur J Cancer; 1997 Oct; 33(12):1929-31. PubMed ID: 9516826
[TBL] [Abstract][Full Text] [Related]
39. Vav1 mutations identified in human cancers give rise to different oncogenic phenotypes.
Shalom B; Farago M; Pikarsky E; Katzav S
Oncogenesis; 2018 Oct; 7(10):80. PubMed ID: 30297765
[TBL] [Abstract][Full Text] [Related]
40. Expression in murine and human neuroblastoma cell lines of VGF, a tissue specific protein.
Rossi A; Granata F; Augusti-Tocco G; Canu N; Levi A; Possenti R
Int J Dev Neurosci; 1992 Dec; 10(6):527-34. PubMed ID: 1288062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
